HOME > TOP STORIES
TOP STORIES
-
REGULATORY Japan Calls for APOE Testing before Leqembi, Kisunla Treatment
August 18, 2026
-
REGULATORY Trazenta Draws 8 Generic Entrants as Japan Clears New DPP-4 Copies
August 17, 2026
-
ORGANIZATION EFPIA Executive Hails Japan’s Honebuto as “Blueprint” for Europe
August 17, 2026
-
BUSINESS Takeda Snares US Approval for Orzeyful in Narcolepsy Type 1
August 7, 2026
-
REGULATORY Nakai Tapped as MHLW’s Top Pharmacy Officer; Ohara to Steer Drug Pricing Reform
August 7, 2026
-
REGULATORY Sarclisa SC, Joenja, Kineret, and 7 More Drugs Bound for NHI Listing
August 6, 2026
-
REGULATORY Chuikyo Clears NHI Listing for Oncolys’ Telomelysin
August 6, 2026
-
BUSINESS AstraZeneca Japan Chief Says MFN Response Requires Drug Pricing Reform
August 5, 2026
-
REGULATORY Outgoing MHLW Pharmacy Chief Eyes AI as Next Frontier for Drug Regulation
August 4, 2026
-
BUSINESS Lilly Blasts Mounjaro Price Cut, Warns over Japan Investment Appeal
August 4, 2026
-
COMMENTARY Signs of Shift in Japan’s Drug Policy, but Cost Pressures Persist
August 3, 2026
-
ORGANIZATION JPMA Chief Seeks Concrete Reforms to Reward Innovation after Honebuto
July 31, 2026
-
BUSINESS Astellas Expands AI Drug Discovery to TPDs, Engineered Proteins
July 30, 2026
-
BUSINESS Some Drug Plants Halt Operations after Kumamoto Temblor, Supplies Unaffected
July 30, 2026
-
BUSINESS Drug Makers, Wholesalers Rush to Gauge Kumamoto Quake Impact
July 29, 2026
-
ORGANIZATION Radiopharma Group Seeks Faster NHI Coverage for PET Imaging Agents
July 28, 2026
-
REGULATORY Japan Panel Green-Lights GSK’s Hep B Drug, Brinsupri, Hyrnuo
July 28, 2026
-
COMMENTARY Rare Cancer Case Raises New Questions about AAV Gene Therapy Safety
July 27, 2026
-
REGULATORY Japan Enacts Revised Immunization Act, Opens Way for RSV Antibodies under NIP
July 27, 2026
-
REGULATORY Japan to Clarify Non-Clinical Data Waivers for Repurposed Drugs, Ease Sakigake Rules
July 24, 2026
ページ
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
